LadRx Corporation
CYTOTOXIC AGENTS FOR THE TREATMENT OF CANCER
Last updated:
Abstract:
The present invention relates to a method of treating brain cancer comprising administering a therapeutically effective substance to a patient, wherein the therapeutically effective substance comprises: (I), or a pharmaceutically acceptable salt thereof, wherein X is a moiety that can be cleaved hydrolytically or enzymatically in the body of the patient in a pH-dependent manner.
Status:
Application
Type:
Utility
Filling date:
19 Feb 2019
Issue date:
21 Nov 2019